GIOS Biostructures has been awarded a VLAIO Innovation Startup Support (ISS) grant
This recognition means a great deal to us. VLAIO plays a crucial role as a catalyst of the strong and…
Blog
Read MoreGIOS Biostructures has been awarded a VLAIO Innovation Startup Support (ISS) grant
Evolution of GPCR research
For decades, GPCRs were paradoxical targets: biologically central, yet structurally elusive. These receptors mediate key signaling pathways involved in sensory…
Is X-ray crystallography nearing the end?
Is X-ray crystallography nearing the end of its era in membrane protein drug discovery?With cryo-EM rapidly evolving and delivering atomic-resolution…
🚄 GIOS is heading to Dutch Life Sciences conference 2025
We look forward to connect with the vibrant Dutch biotech and pharma community, sharing how our platform is helping drive…
GIOS is heading to PSDI 2025
We’re exited to share that GIOS Biostructures will be present at the Protein Structure Determination in Industry (PSDI) 2025 conference.…
Design. Predict. Validate. Realize. The MESO™ Advantage.
Protein design/engineering has entered a new era, fueled by the rise of reliable AI-based methods. This shift has transformed the…